Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:1910-1914
Published online before print August 11, 2005, doi: 10.1161/01.STR.0000177610.33478.65
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/9/1910    most recent
01.STR.0000177610.33478.65v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aronow, H. D.
Right arrow Articles by Yadav, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aronow, H. D.
Right arrow Articles by Yadav, J. S.
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Doppler ultrasound, Transcranial Doppler etc.
Right arrow Angioplasty and Stenting

(Stroke. 2005;36:1910.)
© 2005 American Heart Association, Inc.


Original Contributions

Leukocyte Count Predicts Microembolic Doppler Signals During Carotid Stenting

A Link Between Inflammation and Embolization

Herbert D. Aronow; Mehdi Shishehbor; DonaLee A. Davis; Irene L. Katzan; Deepak L. Bhatt; Christopher T. Bajzer; Alex Abou-Chebl; Krieger W. Derk; Patrick L. Whitlow Jay S. Yadav

From Michigan Heart P.C. (H.D.A.), Ypsilanti, Michigan; and Cleveland Clinic Foundation (M.S., D.A.D., I.L.K., D.L.B., C.T.B., A.A.-C., K.W.D., P.L.W., J.S.Y.), Cleveland, Ohio.

Correspondence to Herbert D. Aronow, MD, MPH, Michigan Heart PC, 5325 Elliott Dr, Suite 203, Ypsilanti, MI 48197. E-mail haronow{at}michiganheart.com

Background and Purpose— Protected stenting has emerged as a safe and effective alternative to endarterectomy for the treatment of carotid stenosis in patients at high operative risk. Distal microembolization occurs invariably during carotid stenting. Little is known about the relationship between systemic inflammation and embolization during carotid stenting.

Methods— We examined 43 consecutive patients who underwent carotid stenting with simultaneous transcranial Doppler (TCD) monitoring of the ipsilateral middle cerebral artery. Embolization was quantified by measuring microembolic signals (MES) on TCD. Preprocedure leukocyte counts were related to MES.

Results— In unadjusted analyses, preprocedure leukocyte count was positively correlated with total procedural MES (r2= 0.16; P=0.008). After considering age, gender, comorbidities, concomitant medical therapies, and the use of emboli prevention devices, increasing leukocyte count (ß=35 for each 1000/µL increment; P=0.018) remained a significant and independent predictor of embolization (model-adjusted r2=0.365; P=0.0005).

Conclusions— Increasing preprocedure leukocyte count independently predicted more frequent MES during carotid stenting. These data suggest that systemic inflammation may influence the degree of procedural embolization.


Key Words: inflammation • leukocytes • stents




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
K. Groschel, U. Ernemann, J. Larsen, M. Knauth, F. Schmidt, J. Artschwager, and A. Kastrup
Preprocedural C-Reactive Protein Levels Predict Stroke and Death in Patients Undergoing Carotid Stenting
AJNR Am. J. Neuroradiol., October 1, 2007; 28(9): 1743 - 1746.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Chaturvedi and J. S. Yadav
The Role of Antiplatelet Therapy in Carotid Stenting for Ischemic Stroke Prevention
Stroke, June 1, 2006; 37(6): 1572 - 1577.
[Abstract] [Full Text] [PDF]